3081 - 3090 of 8571 Results
Title
Year
-
OPENTitle: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the artJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-024-01144-2Best OA location URL: https://www.nature.com/articles/s41746-024-01144-2.pdfCitation Count: 14
-
RESTRICTEDTitle: What matters to people with Parkinson’s disease living in Australia?Journal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 22Issue #: 2Start Page: 338End Page: 341Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2014.06.097Citation Count: 10
- Classification of Parkinson’s disease and isolated REM sleep behaviour disorder: delineating progression markers from the sebum volatilome2025OPENTitle: Classification of Parkinson’s disease and isolated REM sleep behaviour disorder: delineating progression markers from the sebum volatilomeJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01026-8Best OA location URL: https://www.nature.com/articles/s41531-025-01026-8.pdfCitation Count: 0
-
OPENTitle: Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 68Issue #:Start Page: 69End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.10.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9979781Citation Count: 17
- Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET study2019OPENTitle: Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3116End Page: 3128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz260Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3116/30063806/awz260.pdfCitation Count: 83
-
OPENTitle: Lewy body pathology in Alzheimer's disease: A clinicopathological prospective studyJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 139Issue #: 1Start Page: 76End Page: 81Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.13028Citation Count: 42
-
OPENTitle: Fears and uncertainties of people with Parkinson's diseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251328565Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1877718X251328565Citation Count: 0
- The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements2016RESTRICTEDTitle: The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurementsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 105Issue #:Start Page: 651End Page: 660Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.01.013Citation Count: 34
- Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s disease2023OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 1End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/10543406.2023.2170400Citation Count: 7
-
OPENTitle: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2945End Page: 2950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28779Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8688198Citation Count: 135